Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

270 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prostate-specific antigen in nipple aspiration fluid: menstrual cycle variability and correlation with serum prostate-specific antigen.
Mitchell G, Sibley PE, Wilson AP, Sauter E, A'Hern R, Eeles RA. Mitchell G, et al. Tumour Biol. 2002 Sep-Oct;23(5):287-97. doi: 10.1159/000068568. Tumour Biol. 2002. PMID: 12595745
Fatigue in patients with prostate cancer receiving hormone therapy.
Stone P, Hardy J, Huddart R, A'Hern R, Richards M. Stone P, et al. Eur J Cancer. 2000 Jun;36(9):1134-41. doi: 10.1016/s0959-8049(00)00084-8. Eur J Cancer. 2000. PMID: 10854947
Test of association between variant tgβ1 alleles and late adverse effects of breast radiotherapy.
Martin S, Sydenham M, Haviland J, A'Hern R, Owen R, Bliss J, Yarnold J. Martin S, et al. Radiother Oncol. 2010 Oct;97(1):15-8. doi: 10.1016/j.radonc.2010.03.019. Radiother Oncol. 2010. PMID: 20435363 Clinical Trial.
Primary medical therapy for operable breast cancer.
Mansi JL, Smith IE, Walsh G, A'Hern RP, Harmer CL, Sinnett HD, Trott PA, Fisher C, McKinna JA. Mansi JL, et al. Eur J Cancer Clin Oncol. 1989 Nov;25(11):1623-7. doi: 10.1016/0277-5379(89)90308-8. Eur J Cancer Clin Oncol. 1989. PMID: 2512171
Impact of doxorubicin on survival in advanced ovarian cancer.
A'Hern RP, Gore ME. A'Hern RP, et al. J Clin Oncol. 1995 Mar;13(3):726-32. doi: 10.1200/JCO.1995.13.3.726. J Clin Oncol. 1995. PMID: 7884432
Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer.
Kirby AM, A'Hern RP, D'Ambrosio C, Tanay M, Syrigos KN, Rogers SJ, Box C, Eccles SA, Nutting CM, Harrington KJ. Kirby AM, et al. Br J Cancer. 2006 Mar 13;94(5):631-6. doi: 10.1038/sj.bjc.6602999. Br J Cancer. 2006. PMID: 16495923 Free PMC article. Clinical Trial.
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2).
Chua S, Smith IE, A'Hern RP, Coombes GA, Hickish TF, Robinson AC, Laing RW, O'Brien ME, Ebbs SR, Hong A, Wardley A, Mughal T, Verrill M, Dubois D, Bliss JM; TOPIC Trial Group. Chua S, et al. Ann Oncol. 2005 Sep;16(9):1435-41. doi: 10.1093/annonc/mdi276. Epub 2005 Jun 9. Ann Oncol. 2005. PMID: 15946977 Clinical Trial.
A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial.
Smith IE, A'Hern RP, Coombes GA, Howell A, Ebbs SR, Hickish TF, O'Brien ME, Mansi JL, Wilson CB, Robinson AC, Murray PA, Price CG, Perren TJ, Laing RW, Bliss JM; TOPIC Trial Group. Smith IE, et al. Ann Oncol. 2004 May;15(5):751-8. doi: 10.1093/annonc/mdh175. Ann Oncol. 2004. PMID: 15111342 Clinical Trial.
GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): a phase I trial in melanoma.
Vaughan MM, Moore J, Riches PG, Johnston SR, A'Hern RP, Hill ME, Eisen T, Ayliffe MJ, Thomas JM, Gore ME. Vaughan MM, et al. Ann Oncol. 2000 Sep;11(9):1183-9. doi: 10.1023/a:1008348005349. Ann Oncol. 2000. PMID: 11061616 Clinical Trial.
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.
Johnston SR, Constenla DO, Moore J, Atkinson H, A'Hern RP, Dadian G, Riches PG, Gore ME. Johnston SR, et al. Br J Cancer. 1998 Apr;77(8):1280-6. doi: 10.1038/bjc.1998.214. Br J Cancer. 1998. PMID: 9579834 Free PMC article. Clinical Trial.
270 results
Jump to page